🇺🇸 FDA
Patent

US 11866491

Antibody for binding to interleukin 4 receptor

granted A61KA61K38/00A61K39/395

Quick answer

US patent 11866491 (Antibody for binding to interleukin 4 receptor) held by SuZhou Connect Biopharmaceuticals, Inc. expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SuZhou Connect Biopharmaceuticals, Inc.
Grant date
Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K38/00, A61K39/395, A61K45/06, A61P